Glioblastoma and stem cells

Neoplasma

Volumn 55, Issue 5, 2008, Pages 369-374

  Altaner, C ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

BMP4; Cancer stem cells; CD113 marker; Chemoresistance; Glioblastoma; Mesenchymal stem cells; Radio resistance; Rat glioma models; Stem cell based gene therapy; Vascular niche

Indexed keywords

ADENOVIRUS VECTOR; BEVACIZUMAB; BONE MORPHOGENETIC PROTEIN 4; CARMUSTINE; CD133 ANTIGEN; CD45 ANTIGEN; CD71 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; FLUCYTOSINE; GADOLINIUM CHELATE; GANCICLOVIR; RECOMBINANT INTERLEUKIN 2; RETINOIC ACID; STEM CELL FACTOR RECEPTOR; THYMIDINE KINASE 1; VASCULOTROPIN; BONE MORPHOGENETIC PROTEIN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

CANCER GENE THERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CELL PROLIFERATION; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; MEDULLOBLASTOMA; MESENCHYMAL STEM CELL TRANSPLANTATION; NEURAL STEM CELL; NONHUMAN; RADIOSENSITIVITY; SHORT SURVEY; STEM CELL; ANIMAL; BRAIN TUMOR; DRUG DELIVERY SYSTEM; DRUG RESISTANCE; GENE THERAPY; METABOLISM; MOUSE; PATHOLOGY; RADIATION DOSE; REVIEW; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD; BONE MORPHOGENETIC PROTEINS; BRAIN NEOPLASMS; CELL LINE, TUMOR; DNA REPAIR; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; GENE THERAPY; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; MICE; NEOPLASTIC STEM CELLS; PEPTIDES; RADIATION TOLERANCE;

EID: 53449085011     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (45)

1. FURNARI FB, FENTON T, BACHOO RM, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007; 21: 2683-2710.
2. HOELZINGER DB, DEMUTH T, BERENS ME. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst. 2007; 99: 1583-1593.
3. OKA N, SOEDA A, INAGAKI A, et al. VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells. Biochem Biophys Res Commun. 2007; 360: 553-559. (Pubitemid 47048135)
4. REARDON DA, RICH JN, FRIEDMAN HS, et al. Recent advances in the treatment of malignant astrocytoma. J Clin Oncol. 2006; 24: 1253-1265. (Pubitemid 46622028)
5. STOMMEL JM, KIMMELMAN AC, YING H, et al. Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 2007; 318: 287-290.
6. SOLTYSOVA A, ALTANEROVA V, ALTANER C. Cancer stem cells. Neoplasma 2005; 52: 435-440.
7. UCHIDA, N., BUCK, D.W., HE, D. et al. Direct isolation of human central nervous system stem cells. Proc. Natl Acad. Sci. USA 2000; 97, 14720-14725.
8. HEMMATI HD, NAKANO I, LAZAREFF JA. et al. Cancerous stem cells can arise from pediatric brain tumors, Proc. Natl. Acad. Sci. USA 2003; 100: 15178-15183.
9. SINGH SK, CLARKE, ID, TERASAKI M. et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63: 5821-5828.
10. SINGH SK, HAWKINS C CLARKE ID et al. Identification of human brain tumour initiating cells, Nature 2004; 432: 396-401. (Pubitemid 39551674)
11. GALLI R, BINDA E, ORFANELLI U. et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma, Cancer Res. 2004; 64: 7011-7021.
12. YUAN X, CURTIN J, XIONG Y. et al., Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004; 23: 9392-9400. (Pubitemid 40069671)
13. TAYLOR MD, POPPLETON H, FULLER C, et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005; 8: 323-335.
14. BEIER D, HAU P, PROESCHOLDT M, et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007; 67: 4010-4015.
15. CLEMENT V, SANCHEZ P, DE TRIBOLET N, et al.. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol. 2007; 17: 165-172
16. PFENNINGER CV, ROSCHUPKINA T, HERTWIG F, et al. CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells. Cancer Res. 2007; 67: 5727-5736.
17. SEIGEL GM, HACKAM AS, GANGULY A, et al. Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis. 2007; 13: 823-832. (Pubitemid 46908324)
18. RICCI-VITIANI L, LOMBARDI DG, PILOZZI E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115. (Pubitemid 46067311)
19. TANG C, CHUA CLM, ANG BT. Insight into the cancer stem cell model of glioma tumorigenesis. Annals Acad Med Singapure 2007; 36: 352-735.
20. KIM M, MORSHEAD CM. Distinct populations of forebrain neural stem and progenitor cells can be isolated using side-population analysis. J Neurosci 2003; 23: 10703-10709.
21. KANG MK, KANG SK. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev. 2007; 16: 837-847.
22. 1: LIU G, YUAN X, ZENG Z, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer. 2006; 5: 67.
23. LU C, SHERVINGTON A. Chemoresistance in gliomas. Mol Cell Biochem. 2008 Feb 8; [Epub ahead of print]
24. KANG MK, HUR BI, KO MH, et al. Potential identity of multi-potential cancer stem-like subpopulation after radia tion of cultured brain glioma. BMC Neurosci. 2008 30; 9-15.
25. RICH JN. Cancer stem cells in radiation resistance. Cancer Res. 2007; 67: 8980-8984. (Pubitemid 47535877)
26. BAO S, WU Q, SATHORNSUMETEE S, Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 2006; 66: 7843-7848.
27. BAO S, WU Q, MCLENDON RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756-760.
28. CHALMERS AJ. Radioresistant glioma stem cells - therapeutic obstacle or promising target? DNA Repair 2007; 6: 1391-1394.
29. GILBERTSON RJ, RICH JN. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer. 2007; 7: 733-736.
30. GHODS AJ, IRVIN D, LIU G, et al. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells. 2007; 25: 1645-1653.
31. PARTHYMOU A, KARDAMAKIS D, PAVLOPOULOS I,et al.. Irradiated C6 glioma cells induce angiogenesis in vivo and activate endothelial cells in vitro. Int J Cancer. 2004; 110: 807-814.
32. NAKAMURA K, ITO Y, KAWANO Y, et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 2004; 11: 1155-1164.
33. FISCHER YH, MILETIC H, GIROGLOU T, et al. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells. J Gene Med. 2007; 9: 335-344.
34. SELL S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol/Hematol 2004; 51: 1-28. (Pubitemid 38781748)
35. KUCEROVA L, ALTANEROVA V, MATUSKOVA M, et al. Adipose Tissue Derived Human Mesenchymal Stem Cells Mediated Prodrug Cancer Gene Therapy. Cancer Res 2007; 67: 6304-6313.
36. Nakamizo A, Marini F, Amano T, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005; 65: 3307-3318.
37. BIRNBAUM T, ROIDER J, SCHANKIN CJ, et al. Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J Neurooncol. 2007; 83: 241-247.
38. KIM SK, KIM SU, PARK IH, et al. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res. 2006; 12: 5550-5556.
39. UHL M, WEILER M, WICK W, et al.. Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas. Biochem Biophys Res Commun. 2005; 328: 125-129.
40. LIN D, NAJBAUER J, SALVATERRA PM, et al. Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma. Neuroimage 2007; 37 Suppl 1: 18-26.
41. BREKKE C, WILLIAMS SC, PRICE J, et al. Cellular multiparametric MRI of neural stem cell therapy in a rat glioma model. Neuroimage. 2007; 37: 769-782.
42. PICCIRILLO SG, REYNOLDS BA, ZANETTI N, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 2006 7; 444: 761-765.
43. PENG H, WRIGHT V, USAS A, et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 2002; 110: 751-759.
44. PICCIRILLO SG, VESCOVI AL. Bone morphogenetic proteins regulate tumorigenicity in human glioblastoma stem cells. Ernst Schering Found Symp Proc. 2006; 5: 59-81.
45. ABOODY KS, NAJBAUER J, DANKS MK. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Therapy 2008; 15: 739-752.